Compensation
Up to $1,175
Ages
18-75
Gender
Male & Female
Trial Setting
Outpatient
Duration
12 Weeks
A Phase 2 Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder.
The Details
- 6-week trial with pre-screening and post-trial safety follow-up visits
- 18-75
- Male & Female
- Up to $1,175
- Outpatient
Participants Must:
- 18 to 75 years old
- Have Major Depressive Disorder (MDD) with a history of at least one previous Major Depressive Episode (MDE)
- Your current MDE must have started at least 8 weeks ago but not longer than 104 weeks ago
Compensation Information:
- Screening – $200
- Observation / Telephone Call – $75.00
- Baseline – $150.00
- Week One – $150.00
- Week Two – $150.00
- Week Four – $150.00
- Week Six ET/EOT – $150.00
- Safety Follow-Up Week 2 – $150.00
Apply Today
"*" indicates required fields